000046299 000__ 01182cam\a22004095i\4500
000046299 001__ 46299
000046299 003__ SzGeWIPO
000046299 005__ 20240708150236.0
000046299 006__ m\\\\eo\\d\\\\\\\\
000046299 007__ cr bn |||m|||a
000046299 008__ 220610s2020\\\\nyu\\\\\o\\\\\000\0\eng\d
000046299 035__ $$a(OCoLC)1335039367
000046299 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046299 041__ $$aeng
000046299 24500 $$aImpact of Bolar-exemption and compulsory licensing on market exclusivity and the public health crisis - perspective from developing countries.
000046299 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2020
000046299 300__ $$a1 online resource
000046299 336__ $$atext$$2rdacontent
000046299 337__ $$acomputer$$2rdamedia
000046299 338__ $$aonline resource$$bcr$$2rdacarrier
000046299 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 42, Issue 6
000046299 542__ $$fhttps://1.next.westlaw.com/Copyright
000046299 588__ $$aCrossref
000046299 590__ $$aPublished online: 2020
000046299 650_0 $$aIntellectual property.
000046299 650_0 $$aPatents.
000046299 650_0 $$aPharmaceutical policy.
000046299 650_4 $$aCompulsory licensing of patents
000046299 7001_ $$aIqbal, Zarina,$$eauthor.
000046299 7001_ $$aSadaf, Saima,$$eauthor.
000046299 7731_ $$tEuropean Intellectual Property Review
000046299 7731_ $$wEIPR
000046299 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2020, 42(6), 364-375
000046299 85641 $$uhttps://www.westlaw.com/Document/IFB6B5180AAAD11EA8E9EF40903362FD6/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046299 904__ $$aJournal article
000046299 980__ $$aEIPR